These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 16699375

  • 1. Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells.
    Imataki O, Heike Y, Ishida T, Takaue Y, Ikarashi Y, Yoshida M, Wakasugi H, Kakizoe T.
    J Immunother; 2006; 29(3):320-7. PubMed ID: 16699375
    [Abstract] [Full Text] [Related]

  • 2. Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells.
    Imataki O, Heike Y, Makiyama H, Iizuka A, Ikarashi Y, Ishida T, Wakasugi H, Takaue Y.
    Cytotherapy; 2008; 10(5):497-506. PubMed ID: 18608348
    [Abstract] [Full Text] [Related]

  • 3. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
    Huang Y, Jiang EL, Zhou Z, He Y, Wang M, Liu QG, Zhai WJ, Han MZ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):315-20. PubMed ID: 16038267
    [Abstract] [Full Text] [Related]

  • 4. Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.
    Harada Y, Imataki O, Heike Y, Kawai H, Shimosaka A, Mori S, Kami M, Tanosaki R, Ikarashi Y, Iizuka A, Yoshida M, Wakasugi H, Saito S, Takaue Y, Takei M, Kakizoe T.
    J Immunother; 2005 Jun; 28(4):314-21. PubMed ID: 16000949
    [Abstract] [Full Text] [Related]

  • 5. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M.
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [Abstract] [Full Text] [Related]

  • 6. Expansion of Valpha24(+)Vbeta11(+) NKT cells from cord blood mononuclear cells using IL-15, IL-7 and Flt3-L depends on monocytes.
    Okada H, Nagamura-Inoue T, Mori Y, Takahashi TA.
    Eur J Immunol; 2006 Jan; 36(1):236-44. PubMed ID: 16380959
    [Abstract] [Full Text] [Related]

  • 7. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, Tadokoro K, Durrant S, Boyd A, Juji T, Nicol A.
    Br J Cancer; 2001 Sep 01; 85(5):741-6. PubMed ID: 11531261
    [Abstract] [Full Text] [Related]

  • 8. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
    van der Vliet HJ, Molling JW, Nishi N, Masterson AJ, Kölgen W, Porcelli SA, van den Eertwegh AJ, von Blomberg BM, Pinedo HM, Giaccone G, Scheper RJ.
    Cancer Res; 2003 Jul 15; 63(14):4101-6. PubMed ID: 12874013
    [Abstract] [Full Text] [Related]

  • 9. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
    Rogers PR, Matsumoto A, Naidenko O, Kronenberg M, Mikayama T, Kato S.
    J Immunol Methods; 2004 Feb 15; 285(2):197-214. PubMed ID: 14980434
    [Abstract] [Full Text] [Related]

  • 10. Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.
    Osada T, Morse MA, Lyerly HK, Clay TM.
    Int Immunol; 2005 Sep 15; 17(9):1143-55. PubMed ID: 16027139
    [Abstract] [Full Text] [Related]

  • 11. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G, Fujiwara H, Rezvani K, Keyvanfar K, El Ouriaghli F, Grube M, Melenhorst J, Hensel N, Barrett AJ.
    J Leukoc Biol; 2004 Dec 15; 76(6):1214-9. PubMed ID: 15345723
    [Abstract] [Full Text] [Related]

  • 12. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG, Martinson J.
    Cytotherapy; 2004 Dec 15; 6(1):15-22. PubMed ID: 14985163
    [Abstract] [Full Text] [Related]

  • 13. [Expansion and cytokine secretion profile of human valpha24(+) NKT cells from different sources].
    Zhai WH, Huang Y, Wang M, Zhou Z, Zhai WJ, Zhang RL, Zhang P, Han MZ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun 15; 17(3):633-6. PubMed ID: 19549378
    [Abstract] [Full Text] [Related]

  • 14. Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide.
    Ishikawa E, Motohashi S, Ishikawa A, Ito T, Uchida T, Kaneko T, Tanaka Y, Horiguchi S, Okamoto Y, Fujisawa T, Tsuboi K, Taniguchi M, Matsumura A, Nakayama T.
    Int J Cancer; 2005 Nov 01; 117(2):265-73. PubMed ID: 15900581
    [Abstract] [Full Text] [Related]

  • 15. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas.
    Tachibana T, Onodera H, Tsuruyama T, Mori A, Nagayama S, Hiai H, Imamura M.
    Clin Cancer Res; 2005 Oct 15; 11(20):7322-7. PubMed ID: 16243803
    [Abstract] [Full Text] [Related]

  • 16. The effects of natural killer-cell depletion on ex vivo expansion of hematopoietic progenitor cells from umbilical cord blood.
    Sun R, Wei H, Zhang J, Tian Z.
    Haematologica; 2003 May 15; 88(5):561-9. PubMed ID: 12745276
    [Abstract] [Full Text] [Related]

  • 17. Polarization of natural killer T cells towards an NKT2 subpopulation occurs after stimulation with alpha-galactosylceramide and rhG-CSF in aplastic anemia.
    Wang Y, Hu X, Guo C, Zhang Q, Peng J, Zhang J, Li L, Zhang T, Xu C.
    Acta Haematol; 2008 May 15; 119(3):178-86. PubMed ID: 18535366
    [Abstract] [Full Text] [Related]

  • 18. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
    Li K, Li CK, Chuen CK, Tsang KS, Fok TF, James AE, Lee SM, Shing MM, Chik KW, Yuen PM.
    Eur J Haematol; 2005 Feb 15; 74(2):128-35. PubMed ID: 15654904
    [Abstract] [Full Text] [Related]

  • 19. Recovery of Valpha24+ NKT cells after hematopoietic stem cell transplantation.
    Haraguchi K, Takahashi T, Hiruma K, Kanda Y, Tanaka Y, Ogawa S, Chiba S, Miura O, Sakamaki H, Hirai H.
    Bone Marrow Transplant; 2004 Oct 15; 34(7):595-602. PubMed ID: 15300228
    [Abstract] [Full Text] [Related]

  • 20. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.
    Exp Hematol; 2009 Oct 15; 37(10):1216-29. PubMed ID: 19638292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.